Indo-Bangla Pharmaceuticals Limited reported earnings results for the first quarter ended September 30, 2023. For the first quarter, the company reported sales was BDT 85.3 million compared to BDT 121.49 million a year ago. Net income was BDT 0.99068 million compared to BDT 19.87 million a year ago.

Basic earnings per share from continuing operations was BDT 0.01 compared to BDT 0.17 a year ago.